Skip to content

Monoject 8881892950Recalls & reported problems

Cardinal Health 200, LLC · Monoject Magellan 1/2mL Insulin Safety Syringe Permanent Needle 29G x1/2 in. (0.33 x 13 mm) · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10192253025538), received between Aug 7, 2025 and Aug 7, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Fail-Safe Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fail-Safe Problem1

Patient problems

  • Needle Stick/Puncture1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 7, 2025Fail-Safe Problem; Fail-Safe Problem

    THE CUSTOMER REPORTED THAT THE NURSING FLOOR HAS HAD ACCIDENTAL NEEDLESTICK INCIDENTS INVOLVING SYRINGE MODEL 8881892950, ALL DISPENSED BY PHARMACY FOR LONG-ACTING INSULIN ADMINISTRATION. THE CORE SAFETY CONCERN IS THAT THE NEEDLE GUARD ON THIS SYRINGE DOES NOT ENGAGE SMOOTHLY. INITIALLY, IT SLIDES UP AND APPEARS TO STOP, WHICH CAN GIVE THE IMPRESSION THAT THE NEEDLE IS FULLY COVERED. HOWEVER, NURSES NEED TO APPLY ADDITIONAL FORCE BEYOND THIS INITIAL RESISTANCE TO FULLY ACTIVATE THE SAFETY GUARD AND PROPERLY COVER THE NEEDLE. THIS INCOMPLETE CLOSURE CREATES A RISK FOR ACCIDENTAL NEEDLESTICKS. ADDITIONAL INFORMATION RECEIVED ON 24JUL2025 STATED THAT THE NURSES HAD TO DRAW ADDITIONAL EXPOSURE PROTOCOL LAB WORK FOR EACH PATIENT THAT THE NEEDLE STICK OCCURRED WITH AS THEY WERE ALL CONTAMINATED ACCIDENTAL NEEDLE STICKS (I.E. POST INJECTION WITH THE PATIENT). FIRST AID WAS APPLIED TO ALL. THERE WAS EMOTIONAL DISTRESS AND PAPERWORK FOR ALL ENCOUNTERS. ON 29JUL2025 IT WAS CONFIRMED THAT THE NURSES DID NOT REQUIRE LAB WORK OR MEDICATION.

    Patient problems: Needle Stick/Puncture

    MAUDE report 22743839 ↗

Other Syringe, piston devices

All Syringe, piston devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.